TABLE 1

Patient Characteristics

Patient no.Age (y)SexTumor typePrevious treatment*
159MFollicular thyroid cancerIsotretinoin redifferentiation therapy
266MNeuroendocrine tumor90Y-DOTATOC therapy
360MNeuroendocrine tumorSandostatin therapy
456MNeuroendocrine tumorTransabdominal chemoembolization
574MNeuroendocrine tumorHemihepatectomy
  • * 111In-DTPA-octreotide and 111In-DOTA-BASS scans were performed more than 3 mo after termination of treatment.